Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marschner

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Medical Journal of Australia|October 28, 2019
Biostatistics: a fundamental discipline at the core of modern health data scienceKatherine J Lee, Margarita Moreno-Betancur, Jessica Kasza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimusChee Khoon Lee, Ian C Marschner, R John Simes, et al.
Therapeutic Advances in Medical Oncology|August 11, 2018
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysisKatrin M Sjoquist, Sarah J Lord, Michael L Friedlander, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2018
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic ReviewRoss A McKinnon, Matthew Cook, Winston Liauw, et al.
BMJ Medicine|September 22, 2023
Transparent reporting of adaptive clinical trials using concurrently randomised cohortsIan C Marschner, Mark Jones, James A Totterdell, et al.
Cancer|January 28, 2022
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancerAngelina Tjokrowidjaja, Sarah J Lord, Thomas John, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell linesJ R Zalcberg, X F Hu, M Ching, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2024
Challenges of estimating treatment effects after a positive interim analysisYu Yang Soon, Ian C Marschner, Manjula Schou, et al.
Journal of Clinical Microbiology|March 1, 1997
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.
The Journal of Pediatrics|October 14, 2018
Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen TrialsBenjamin J Stenson, Mark Donoghoe, Peter Brocklehurst, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Medical Journal of Australia|October 28, 2019
Biostatistics: a fundamental discipline at the core of modern health data scienceKatherine J Lee, Margarita Moreno-Betancur, Jessica Kasza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimusChee Khoon Lee, Ian C Marschner, R John Simes, et al.
Therapeutic Advances in Medical Oncology|August 11, 2018
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysisKatrin M Sjoquist, Sarah J Lord, Michael L Friedlander, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2018
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic ReviewRoss A McKinnon, Matthew Cook, Winston Liauw, et al.
BMJ Medicine|September 22, 2023
Transparent reporting of adaptive clinical trials using concurrently randomised cohortsIan C Marschner, Mark Jones, James A Totterdell, et al.
Cancer|January 28, 2022
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancerAngelina Tjokrowidjaja, Sarah J Lord, Thomas John, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell linesJ R Zalcberg, X F Hu, M Ching, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2024
Challenges of estimating treatment effects after a positive interim analysisYu Yang Soon, Ian C Marschner, Manjula Schou, et al.
Journal of Clinical Microbiology|March 1, 1997
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.
The Journal of Pediatrics|October 14, 2018
Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen TrialsBenjamin J Stenson, Mark Donoghoe, Peter Brocklehurst, et al.
Pageof 10